2'-deoxy-2'-fluoro-2'-C-methylcytidine Chemical Properties

Melting point:

216-218℃

Boiling point:

482.4±55.0 °C(Predicted)

Density 

1.67

storage temp. 

Hygroscopic, -20°C Freezer, Under inert atmosphere

solubility 

Methanol (Slightly), Water (Slightly)

pka

12.86±0.70(Predicted)

form 

Solid

color 

White to Light Brown

Stability:

Hygroscopic

2'-deoxy-2'-fluoro-2'-C-methylcytidine Usage And Synthesis

Description

PSI-6130 is a nucleoside inhibitor of the NS5B RNA polymerase of hepatitis C virus (HCV; K_i = 4.3 μM). It inhibits HCV genotype 1b (GT-1b) Con1 and GT-1a H77 viral replication in Huh7 replicon cells using a luciferase-based assay (EC₅₀s = 0.51 and 0.30 μM, respectively). PSI-6130 also inhibits replication of HCV GT-1b and GT-1a replicons from clinical isolates, with EC₅₀ values ranging from 0.60 to 1.41 μM, and 0.20 to 0.43 μM, respectively, in the same assay. It has little or no activity against West Nile Virus (WNV), Dengue type 2 virus (DV), human immunodeficiency virus (HIV), or hepatitis B virus (HBV; EC₉₀s = 46.3, >100, >100, and >10 μM, respectively).

Uses

PSI-6130 is an experimental treatment for hepatitis C. PSI-6130 is a member of a class of antiviral drugs known as nucleoside polymerase inhibitors. PSI-6130 inhibits the hepatitis C virus RNA dependant RNA polymerase called NS5B.

target

Hepatitis C Virus Nucleoside

2'-deoxy-2'-fluoro-2'-C-methylcytidine(817204-33-4)Related Product Information

• (3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxyMethyl)-3-Methyl-dihydrofuran-2(3H)-one
• 4-Pyridinecarboxamide, 3-chloro-N-methyl-
• 3-Pyridinecarboxamide, 4-chloro-N-methyl-
• ((2R,3S,4S)-3-(benzoyloxy)-4-fluoro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl benzoate
• N4-Benzoylcytosine
• (2R)-2-Deoxy-2-fluoro-2-Methyl-D-erythro-pentonic acid-g-lactone 3,5-bis(4-chlorobenzoate)
• 2'-C-Methyl-, 2',3',5'-tribenzoateuridine
• 3-Pyridinecarboxamide, 5-chloro-N-methyl-
• 2'-deoxy-2'-fluoro-2'-C-methyluridine
• HUMAN MDC (CCL22)
• 3-Aminobenzotrifluoride